ACTION

Advance Care Planning; an Innovative Palliative Care Intervention to Improve Quality of Life in Cancer Patients - a Multi-Centre Cluster Randomized Clinical Trial

Coordinatore	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM    more  Organization address address: 's Gravendijkwal 230 city: ROTTERDAM postcode: 3015CE contact info Titolo: Mr. Nome: J.Th.N. Koos Cognome: Lubbe Email: send email Telefono: +31 10 703 84 84 Fax: +31 10 703 84 51
Nazionalità Coordinatore	Netherlands [NL]
Sito del progetto	http://www.action-acp.eu/
Totale costo	6˙122˙871 €
EC contributo	4˙784˙656 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2013-INNOVATION-1
Funding Scheme	CP-FP
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-12-01   -   2018-11-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM  Organization address address: 's Gravendijkwal 230 city: ROTTERDAM postcode: 3015CE contact info Titolo: Mr. Nome: J.Th.N. Koos Cognome: Lubbe Email: send email Telefono: +31 10 703 84 84 Fax: +31 10 703 84 51	NL (ROTTERDAM)	coordinator	1˙573˙657.00
2	VRIJE UNIVERSITEIT BRUSSEL  Organization address address: PLEINLAAN 2 city: BRUSSEL postcode: 1050 contact info Titolo: Mr. Nome: Nik Cognome: Claesen Email: send email Telefono: 3226292210 Fax: 3226293640	BE (BRUSSEL)	participant	658˙602.00
3	ISTITUTO PER LO STUDIO E LA PREVENZIONE ONCOLOGICA  Organization address address: VIA COSIMO IL VECCHIO 2 city: Florence postcode: 50139 contact info Titolo: Dr. Nome: Guido Cognome: Miccinesi Email: send email Telefono: +39 0557972503 Fax: +39 0557972535	IT (Florence)	participant	511˙225.00
4	Bolnisnica Golnik Klinicni oddelek za pljucne bolezni in alergijo  Organization address address: GOLNIK 36 city: GOLNIK postcode: 4204 contact info Titolo: Mrs. Nome: Lea Cognome: Ulcnik Email: send email Telefono: +386 4 25 69 450 Fax: +386 4 25 69 442	SI (GOLNIK)	participant	496˙864.00
5	KOBENHAVNS UNIVERSITET	DK	participant	487˙600.00
6	THE UNIVERSITY OF NOTTINGHAM  Organization address address: University Park city: NOTTINGHAM postcode: NG7 2RD contact info Titolo: Mr. Nome: Paul Cognome: Cartledge Email: send email Telefono: +44 115 8466757 Fax: +44 115 9513633	UK (NOTTINGHAM)	participant	386˙208.00
7	LANCASTER UNIVERSITY  Organization address address: BAILRIGG city: LANCASTER postcode: LA1 4YW contact info Titolo: Mr. Nome: Roderick Cognome: O'brien Email: send email Telefono: +44 1524 592002	UK (LANCASTER)	participant	364˙500.00
8	UNIVERSITAIR MEDISCH CENTRUM UTRECHT  Organization address address: HEIDELBERGLAAN 100 city: UTRECHT postcode: 3584 CX contact info Titolo: Prof. Nome: Hans Cognome: Van Delden Email: send email Telefono: +31 887559361	NL (UTRECHT)	participant	306˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Advanced cancer typically involves multiple symptoms and seriously affects patients´ quality of life. Anxiety and depression are common. Medical care for patients with advanced cancer should be aimed at symptom control, psychosocial support, spiritual needs, and practical issues. Patients’ preferences regarding care should be central. Open and respectful communication are of key importance, but have been found to be a challenge for health care professionals as well as patients and relatives. Advance care planning (ACP) is a formalised process of communication between patients, relatives and caregivers about patients’ care preferences. It raises awareness of the need to anticipate future deterioration of health. ACP can improve current and future health care decision making, provide patients with a sense of control, increase adequate symptom control and improve quality of life. This project aims to study the effects of formalized ACP on symptom burden and quality of life of patients with advanced cancer. In a phase III multicentre cluster randomized controlled trial at least 20 hospitals in 6 countries will be randomized to provide patients with advanced cancer with either ACP or ‘care as usual’. 1334 patients diagnosed with lung or stage IV colorectal cancer will be included. Patients will fill in questionnaires at inclusion, and at 2.5 and 4.5 months post-inclusion. A relative will fill in a questionnaire after the patient’s death. Use of medical care will be assessed through medical files. Primary endpoints are quality of life (QLQ-C30 emotional functioning) and symptoms at 2.5 months post-inclusion. Secondary endpoints are the extent to which care as received was in line with patients’ preferences, patients’ evaluation of the decision making process, quality of dying and cost-effectiveness of the intervention. Our project will assess the impact of ACP on quality of life, and contribute to improving comfort and quality of care for patients with advanced cancer.'